Related Articles
KRAS mutation in patients with metastatic colorectal cancer does not preclude benefit from oxaliplatin‑ or irinotecan‑based treatment
Mutation analysis and genomic imbalances of cells found in effusion fluids from patients with ovarian cancer
Mutation of the PIK3CA gene as a prognostic factor in patients with colorectal cancer
EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab
Effects of BRAF V600E and NRAS mutational status on the progression‑free survival and clinicopathological characteristics of patients with melanoma